Progress of research on pathogenesis of diabetic retinopathy

International Journal of Ophthalmology

Volumn 8, Issue 11, 2008, Pages 2308-2311

  Lu, Bai Yang ^a   Wu, Zhi Feng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Diabetic retinopathy; Pathogenesis; Retina

Indexed keywords

POLYOL;

ARTICLE; BLINDNESS; BLOOD RETINA BARRIER; CELL GROWTH; DIABETIC RETINOPATHY; DISEASE COURSE; GLYCATION; HYPERGLYCEMIA; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN METABOLISM; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RISK FACTOR;

EID: 57349151686     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Morley JE. Diabetes and aging: epidemiologic over view. Clin Geriatr Med 2008;24(3):395-405
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-986
3. Frank RN. Diabetic retinopathy. N Engl J Med 2004;350:48-58
4. Hellstrm M, Gerhardt H, Kale'n M, et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001;153(3):543-553
5. Hirschi KK, D' Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996;32(4):687-698
6. Dagher Z, Park YS, Asnaghi V, et al. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 2004;53(9):2404-2411
7. Asnaghi V, Gerhardinger C, Hoehn T, et al. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003;52(2):506-511
8. Obrosova IG, Minchenko AG, Vasupuram R, et al. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotoci-diabetic rats. Diabetes 2003;52(3):864-871
9. Li J, Hu YH. Susceptibility genes for diabetic retinopathy. Int J Ophthalmol (Guoji Yanke Zazhi) 2008;8(2):234-239
10. Cheung AK, Fung MK, Lo AC, et al. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 2005;54 (11):3119-3125
11. Sun W, Oates PJ, Coutcher JB, et al. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes 2006;55(10): 2757-2762
12. Wautier JL, Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy. Diabete Metab 2001; 27(5):535-542
13. Stitt AW, Li YM, Gardiner TA, et al. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 1997;150(2):523-531
14. Lecleire-Collet A, Tessier LH, Massin P, et al. Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants. Br J Ophthalmol 2005;89(12):1631-1633
15. Moore TC, Moore JE, Kaji Y, et al. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 2003;44(10):4457-4464
16. Li WL, Jiang DY, Guo LH, et al. Pueravin inhibits the prociferation of human retinal pigment epithelial cells and the expression of hypoxia-inducible factor-1α ix in human PRE cells induced by advanced glycation end products. Int J Ophthalmol (Guoji Yanke Zazhi) 2006;6(3):580-583
17. Treins C, Giorgetti-Peraldi S, Murdaca J, et al. Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem 2001;276(47):43836-43841
18. Antonetti DA, Barber AJ, Hollinger LA, et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999;274(33): 23463-23467
19. Agardh E, Hultberg B, Agardh C. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. Curr Eye Res 2000;21(1):543-549
20. Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 2001;50(7):1636-1642
21. Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41(12): 3972-3978
22. Lu TT, Yan LG, Madri JA. Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA 1996;93(21):11808-11813
23. Bursell SE, Clermont AC, Kinsley BT, et al. Retinal blood flow changes in patients with insulindependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 1996;37(5):886-897
24. Miyamoto K, Ogura Y, Nishiwaki H, et al. Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes. Invest Ophthalmol Vis Sci 1996;37 (5):898-905
25. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331(22):1480-1487
26. MacGregor LC, Matschinsky FM. Altered retinal metabolism in diabetes. II. Measurement of sodium potasium ATPase and total sodium and potassium in individual retinal layers. J Biol Chem 1986;261(9) 4052-4058
27. Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003;35 (11):1491-1499
28. Cui Y, Xu X, Bi H, et al. Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp Eye Res 2006;83(4):807-816
29. Cutler RG. Oxidative stress profiling: part I. Its potential importance in the optimization of human health. Ann N Y Acad Sci 2005;1055: 93-135
30. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50(8):1938-1942
31. Haskins K, Bradley B, Powers K, et al. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 2003;1005:43-54
32. Takamura Y, Tomomatsu T, Kubo E, et al. Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells. Invest Ophthalmol Vis Sci 2008;49 (7): 3216-3223
33. Kowluru RA. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci 2005;76(9):1051-1060
34. Du XL, Edelstein D, Rossetti L, et al. Hyperglycemiainduced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000;97(22):12222-12226
35. Ha WJ, Yan H. The role of inflammationin diabetic retinopathy. Int J Ophthalmol (Guoji Yanke Zazhi) 2005;5(4):745-749
36. Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999;96(19):10836-10841
37. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 2001;50(6): 1432-1439
38. Kowluru RA, Koppolu P, Chakrabarti S, et al. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radical Research 2003;37(11):1169-1180
39. Zheng L, Szabó C, Kern TS. Poly (ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004;53(11):2960-2967
40. Zheng L, Du Y, Miller C, et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 2007;50(9):1987-1996
41. Ayalasomayajula SP, Amrite AC, Kompella UB. Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas. Eur J Pharmacol 2004;498(1-3):275-278
42. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha. suppres-sion. FASEB J 2002;16(3):438-440
43. Zhang XL, Qiu SD, Chen YJ, et al. An overview of the pathogenesis of diabetic retinopathy. Int J Ophthalmol (Guoji Yanke Zazhi) 2005;5 (6):1239-1241
44. Li H, Hu XL. Role of vascular endothelial growth factor in the progress of diabetic retinopathy. Int J Ophthalmol (Guoji Yanke Zazhi) 2008;8(5):990-993
45. Poulaki V, Joussen AM, Mitsiades N, et al. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 2004; 165(2):457-469
46. Meyer-Schwickerath R, Pfeiffer A, Blum WF, et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 1993;92(6): 2620-2625
47. Liu H, Ren JG, Cooper WL, et al. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci USA 2004;101(17):6605-6610
48. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285(5425): 245-248
49. Li Y, Lu Y. Perspectivers mechanism of diabetic retinopathy in early stage. Int J Ophthalmol (Guoji Yanke Zazhi) 2005;5(4):750-754
50. Chen Y, Zhu XH. The pathologic mechanism of diabetic retinopathy. Int J Ophthalmol (Guoji Yanke Zazhi) 2006;6(2):433-435